The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

Now Viewing

EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

EP: 2.Strategies for Prevention and Screening of CRM Conditions

EP: 3.The Link Between Obesity and CRM Conditions

EP: 4.Challenges in Managing Co-Morbid CRM Conditions

EP: 5.Contemporary Guidelines for CRM Conditions

EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions

Video content above is prompted by the following:

• What is the clinical and economic burden of Cardiorenal Metabolic Disease (CRM) conditions such as type 2 diabetes, chronic kidney disease, cardiovascular disease and heart failure in the United States?
• How do CRM conditions affect patient quality of life and clinical outcomes?
• How do these conditions impact healthcare resource utilization?
• The CDC has announced that over 42% of adults have obesity; what role does obesity play in the prevalence of CRM conditions in the United States?
• Is this your experience in your practice?

This activity is supported by an educational grant from Boehringer Ingelheim.